The genomic landscape of pediatric myelodysplastic syndromes
Myelodysplastic syndromes (MDS) are uncommon in children and have poor prognosis. Here, the authors interrogate the genomic landscape of MDS, confirming adult and paediatric MDS are separate diseases with disparate mechanisms, and highlighting that SAMD9/SAMD9L mutations represent a new class of MDS...
Guardado en:
Autores principales: | Jason R. Schwartz, Jing Ma, Tamara Lamprecht, Michael Walsh, Shuoguo Wang, Victoria Bryant, Guangchun Song, Gang Wu, John Easton, Chimene Kesserwan, Kim E. Nichols, Charles G. Mullighan, Raul C. Ribeiro, Jeffery M. Klco |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4725852501c4cd68e3d57d74d9225b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
por: Jason R. Schwartz, et al.
Publicado: (2021) -
The landscape of coding RNA editing events in pediatric cancer
por: Ji Wen, et al.
Publicado: (2021) -
Clonal evolution in myelodysplastic syndromes
por: Pedro da Silva-Coelho, et al.
Publicado: (2017) -
TP53 in Myelodysplastic Syndromes
por: Yan Jiang, et al.
Publicado: (2021) -
Managing myelodysplastic symptoms in elderly patients
por: R Ria, et al.
Publicado: (2009)